Journal of Cardiac Failure
Volume 15, Issue 9 , Pages 775-781, November 2009

Role of Ischemic Preconditioning and Inflammatory Response in the Development of Malignant Ventricular Arrhythmias After Reperfused ST-Elevation Myocardial Infarction

  • Hidehiro Kaneko, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Toshihisa Anzai, MD, FACC

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
    • Corresponding Author InformationCorrespondence to: Toshihisa Anzai, MD, Division of Cardiology, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Tel: +81-3-5363-3793; Fax: +81-3-3353-2502.
  • ,
  • Kotaro Naito, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Takashi Kohno, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Yuichiro Maekawa, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Toshiyuki Takahashi, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Akio Kawamura, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Tsutomu Yoshikawa, MD, FACC

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • ,
  • Satoshi Ogawa, MD, FACC

      Affiliations

    • Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan

Received 16 January 2009; received in revised form 8 April 2009; accepted 4 May 2009. published online 29 June 2009.

Abstract 

Background

Sustained ventricular tachycardia and ventricular fibrillation (VT/VF) are major complications of ST-elevation myocardial infarction (STEMI), even in the era of reperfusion therapy. We sought to clarify the determinants of VT/VF after reperfused STEMI.

Methods and Results

Consecutive STEMI patients treated with primary percutaneous coronary intervention (n=457) were divided into 2 groups by the presence or absence of VT/VF during hospitalization. Serum C-reactive protein (CRP) level and peripheral white blood cell (WBC) count were serially measured. VT/VF was observed in 54 patients (12%). Prior infarction was more common and preinfarction angina was less in patients with VT/VF than those without. Peak CRP level (P < .0001), WBC count on admission (P=.008), and maximum WBC count (P=.0014) were higher in patients with VT/VF than those without. VT/VF, especially VT/VF later than 48hours after onset, was associated with greater left ventricular (LV) dimension during convalescence. Kaplan-Meier curves and log-rank test revealed VT/VF to be a significant determinant of long-term major adverse cardiac events. Multivariate analysis revealed that prior infarction, absence of preinfarction angina, and peak CRP ≥10mg/dL were independent determinants of VT/VF.

Conclusions

Lack of ischemic preconditioning, enhanced inflammatory response, and subsequent LV dysfunction are related to the development of VT/VF after STEMI.

Key Words: Ventricular arrhythmia, post-infarction inflammation, ischemic preconditioning

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the Global Center of Excellence (G-COE) Program at Keio University (H.K.) and the Medical School Faculty and Alumni Grant from Keio University Medical Science Fund (T.A.).

 No conflicts of interest exist in this study.

PII: S1071-9164(09)00143-2

doi:10.1016/j.cardfail.2009.05.001

Journal of Cardiac Failure
Volume 15, Issue 9 , Pages 775-781, November 2009